NDC 63323-965-01 - Potassium Chloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-965
- Requested NDC
- 63323-965-01
- Package NDCs from labels
- 63323-965-01, 63323-965-05, 63323-965-03, 63323-965-10, 63323-965-02, 63323-965-20
- Manufacturer
- Henry Schein, Inc.
- Effective date
- 2025-08-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE, USP | Henry Schein, Inc. | 2025-08-12 | HUMAN PRESCRIPTION DRUG LABEL |
| Potassium Chloride - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2023-02-27 | HUMAN PRESCRIPTION DRUG LABEL |
| Potassium Chloride - General Injectables & Vaccines, Inc | General Injectables & Vaccines, Inc | 2022-12-29 | HUMAN PRESCRIPTION DRUG LABEL |
| POTASSIUM CHLORIDE - General Injectables & Vaccines, Inc. | General Injectables & Vaccines, Inc. | 2022-12-29 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-965-01 | Potassium Chloride | 5 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION, CONCENTRATE | 5 | 5 | |
| 63323-965-02 | Potassium Chloride | 20 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION, CONCENTRATE | 20 | 5 | |
| 63323-965-03 | Potassium Chloride | 10 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION, CONCENTRATE | 10 | 5 | |
| 63323-965-05 | Potassium Chloride | 25 in 1 TRAY | INJECTION, SOLUTION, CONCENTRATE | 25 | 5 | |
| 63323-965-10 | Potassium Chloride | 25 in 1 TRAY | INJECTION, SOLUTION, CONCENTRATE | 25 | 5 | |
| 63323-965-20 | Potassium Chloride | 25 in 1 TRAY | INJECTION, SOLUTION, CONCENTRATE | 25 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-965-01 | ML - Milliliter | 63323-965 | 1bbfa031-5c7d-4660-bfc1-4d4f0c7b4049 | 1 | 2019-10-07 |
| 63323-965-02 | ML - Milliliter | 63323-965 | eb59be88-d60b-48d6-ae5b-4790007c02c5 | 1 | 2019-09-05 |
| 63323-965-03 | ML - Milliliter | 63323-965 | f645fe1e-bd3d-4cdc-99db-7744f42ecbab | 1 | 2019-10-07 |
| 63323-965-05 | ML - Milliliter | 63323-965 | 1908bab0-016a-48b3-93bc-249396e92c07 | 1 | 2012-07-24 |
| 63323-965-10 | ML - Milliliter | 63323-965 | 8be2fd64-e5a7-4231-b851-2399e724fac7 | 1 | 2012-07-24 |
| 63323-965-20 | ML - Milliliter | 63323-965 | 346766e4-da06-4c17-94c3-4ef8fe05b96e | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Physicians Care Eyewash | EYEWASH | Acme United Corporation | 3e239b12-9a75-339d-e063-6294a90a72ae | 2025-09-06 | Warnings | 059QF0KO0R |
| Potassium Chloride | POTASSIUM CHLORIDE | Major Pharmaceuticals | 7c2274f2-5a7f-4a4a-8b7b-44f6ef9a84a4 | 2025-09-05 | Warnings, Adverse reactions | 660YQ98I10 |
| Polyethylene Glycol 3350 and electrolytes - Unflavored | POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES - UNFLAVORED | Strides Pharma Science Limited | 48c741a9-9039-4fdb-a875-86d4ea968282 | 2025-09-05 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 3dfa63fc-f8de-f1e0-e063-6294a90a8d47 | 2025-09-04 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 3dfac7ca-2c2e-e709-e063-6394a90adbb3 | 2025-09-04 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Kesin Pharma Corporation | 440dcbbb-bb31-d3fd-e063-6294a90ab2f7 | 2025-09-01 | Warnings, Adverse reactions | 660YQ98I10 |
| Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride - Unflavored | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE - UNFLAVORED | Strides Pharma Science Limited | 37c111ec-5b62-42b9-bbb2-3b0c530e34c9 | 2025-09-01 | Warnings, Adverse reactions | 660YQ98I10 |
| Sterile Water | WATER INJECTION | Henry Schein, Inc. | 3501952b-b556-4d5e-b81b-5c35ff87b475 | 2025-08-28 | Warnings, Adverse reactions | 059QF0KO0R |
| Potassium Chloride | POTASSIUM CHLORIDE | A-S Medication Solutions | 8f6ea056-5e10-4de1-97f0-55f0655a6f78 | 2025-08-27 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | A-S Medication Solutions | 8757d093-747b-4e97-af6d-4064b16178b2 | 2025-08-27 | Warnings, Adverse reactions | 660YQ98I10 |
| Allergy and Sinus Relief | PELARGONIUM SIDOIDES ROOT, HYDRASTIS CANADENSIS WHOLE, POTASSIUM CHLORIDE, SANGUINARIA CANADENSIS ROOT, PULSATILLA VULGARIS, SILICON DIOXIDE | Schwabe North American, Inc. | c90cc6f5-14ec-41a3-a20a-4e8018bb02fb | 2025-08-25 | Warnings | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | American Health Packaging | 149770d0-3a2c-4e75-80a3-ec842907920d | 2025-08-25 | Warnings, Adverse reactions | 660YQ98I10 |
| Schuessler Tissue Salts Comb D Skin Disorders | KALI MURIATICUM,KALI SULPHURICUM,CALCAREA SULPHURICA,SILICEA | Martin & Pleasance Pty Ltd | 617303f8-4463-4a1e-a502-44abc181d91f | 2025-08-13 | Warnings | 660YQ98I10 |
| Schuessler Tissue Salts Comb D Skin Disorders | KALI MURIATICUM,KALI SULPHURICUM,CALCAREA SULPHURICA,SILICEA | Martin & Pleasance Pty Ltd | 03153d92-dc68-4b84-a8c9-634b1ffd7da1 | 2025-08-13 | Warnings | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Henry Schein, Inc. | bf8e8ac7-e6a8-4571-a0ea-7bcab89290f6 | 2025-08-12 | Warnings, Adverse reactions | ANDA088901 0404-9936-20 0404-9936-10 0404-9936 1860139 1860132 86d210da-05db-45c6-b2fd-4d6aa79484fa bf8e8ac7-e6a8-4571-a0ea-7bcab89290f6 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | AvKARE | 3bdfced1-6e62-9e92-e063-6294a90a28aa | 2025-08-08 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride Extended-Release | POTASSIUM CHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 3be29fcc-765e-8653-e063-6394a90a59d5 | 2025-08-08 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Slate Run Pharmaceuticals, LLC | 94ae03cc-b620-0dbb-e053-2a95a90a922c | 2025-08-07 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Slate Run Pharmaceuticals, LLC | 0cc57ece-f15a-4160-a5ea-8d6fa9f9e754 | 2025-08-07 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 47a87fb6-5e61-41c9-b759-10f7c74a67ce | 2025-08-05 | Warnings, Adverse reactions | 660YQ98I10 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.